Research work · 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argilés, Niall Christopher Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark F. Kozloff, Neil Howard Segal, Alberto Felice Sobrero, Yibing Yan, Ilsung Chang, Anne R. Uyei, Louise Roberts, Fortunato Ciardiello, JB Ahn, Jamil Asselah, Suprith Badarinath, Shobhit Baijal
The Lancet Oncology